Nebivolol Tablet
NDC Package 72205-151-99
Package Information
Nebivolol tablets is nebivolol is contraindicated in the following conditions: • Severe bradycardia • Heart block greater than first degree • Patients with cardiogenic shock • Decompensated cardiac failure • Sick sinus syndrome (unless a permanent pacemaker is in place) • Patients with severe hepatic impairment (Child-Pugh >B) • Patients who are hypersensitive to any component of this product. This formulation utilizes a tablet delivery system. Marketed by Novadoz Pharmaceuticals Llc, this product is identified by NDC 72205-151 and is authorized under FDA application ANDA217397.
Identification & Billing
- RxCUI: 387013 - nebivolol 5 MG Oral Tablet
- RxCUI: 387013 - nebivolol (as nebivolol hydrochloride) 5 MG Oral Tablet
- RxCUI: 751612 - nebivolol 10 MG Oral Tablet
- RxCUI: 751612 - nebivolol (as nebivolol hydrochloride) 10 MG Oral Tablet
- RxCUI: 751618 - nebivolol 2.5 MG Oral Tablet
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 72205 - Novadoz Pharmaceuticals Llc
- 72205-151 - Nebivolol
- 72205-151-99 - 100 TABLET in 1 BOX, UNIT-DOSE
- 72205-151 - Nebivolol
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (72205-151). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 72205-151-99 identifies a specific commercial package of 100 tablet in 1 box, unit-dose of Nebivolol, a human prescription drug labeled by Novadoz Pharmaceuticals Llc. This tablet is formulated for oral use and contains nebivolol hydrochloride as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Novadoz Pharmaceuticals Llc on October 01, 2024. The current certification is valid through December 31, 2026.
How is this Novadoz Pharmaceuticals Llc product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 72205015199. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.